Scott Rottinghaus
Chief Tech/Sci/R&D Officer chez ENANTA PHARMACEUTICALS, INC.
Fortune : 493 891 $ au 31/03/2024
Profil
Scott T.
Rottinghaus is currently the Chief Medical Officer & Senior Vice President at Enanta Pharmaceuticals, Inc. Previously, he worked as the Vice President & Head-Clinical Development at Alexion Pharmaceuticals, Inc. He received his doctorate from Mayo Medical School, his graduate degree from the University of Cambridge, and his undergraduate degree from Kansas State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/02/2024 | 28 287 ( 0,13% ) | 493 891 $ | 31/03/2024 |
Postes actifs de Scott Rottinghaus
| Sociétés | Poste | Début |
|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 08/08/2022 |
Anciens postes connus de Scott Rottinghaus
| Sociétés | Poste | Fin |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Scott Rottinghaus
| University of Cambridge | Graduate Degree |
| Kansas State University | Undergraduate Degree |
| Mayo Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ENANTA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
